Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04717297 · ClinicalTrials.gov registry record · NA
Tailored Medication Management Intervention
A NA study of Polypharmacy and Medication Non Adherence, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 33
- Enrollment target
- 1
- Study location
NCT04717297: Completed NA study of Polypharmacy and Medication Non Adherence, sponsored by Washington University School of Medicine.
NCT04717297 is a NA study of Polypharmacy and Medication Non Adherence that has completed, run by Washington University School of Medicine. The registered enrollment target is 33 participants, below the 1,527-participant average among 11 other Polypharmacy trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04717297, a NA study of Polypharmacy and Medication Non Adherence, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 33 participants
- Enrollment target
- 1
- Study location
Study Summary
Successful medication management is an essential instrumental activity of daily living (IADL) for older adults with polypharmacy; however, between 40%-70% of older adults fail to take their medications as prescribed. Providing interventions to address medication management and restore performance for this IADL is within the scope of practice for occupational therapy (OT), however, there is paucity of evidence for OT interventions to improve medication management in community-dwelling older adults. We have developed a tailored medication management intervention (TIMM) for community-dwelling older adults which recognizes the unique context in which medication management occurs (the home) and addresses the personal and environmental barriers experienced by older adults. TIMM is delivered in the home, by an OT, and in collaboration with a pharmacist to reduce inappropriate polypharmacy.
Primary Outcome
Recruitment and retention rate
Conditions Studied
Interventions
- BEHAVIORAL Waitlist Control
- BEHAVIORAL Medication Management Remote Intervention
- BEHAVIORAL Medication Management In-Person Intervention
Study Locations (1)
Missouri
- Washington University - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2021-02-19 |
| Est. Completion | 2022-12-31 |
| Phase | NA |
What the finished NCT04717297 record still lists
NCT04717297 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 33 participants, a relatively small participant target, below the 1,527-participant average among 11 other Polypharmacy trials with a reported enrollment target (98% lower).
The record links to 2 conditions, with Polypharmacy appearing as the primary indexed condition, and to 3 interventions - of which Waitlist Control is the first listed.
NCT04717297 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT04717297 about?
NCT04717297 is a clinical study titled "Tailored Medication Management Intervention". Successful medication management is an essential instrumental activity of daily living (IADL) for older adults with polypharmacy; however, between 40%-70% of older adults fail to take their medications as prescribed. Providing interventions to address medication management and restore performance fo...
What is the current status of trial NCT04717297?
This trial is currently completed. It is a NA study. The enrollment target is 33 participants. The study started on 2021-02-19. Estimated completion is 2022-12-31.
What conditions does trial NCT04717297 study?
This clinical trial studies the following conditions: Polypharmacy, Medication Non Adherence.
What interventions are being tested in trial NCT04717297?
The interventions under investigation include: Waitlist Control (BEHAVIORAL), Medication Management Remote Intervention (BEHAVIORAL), Medication Management In-Person Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT04717297?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04717297 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Polypharmacy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04717297's enrollment target sits among peer trials
33 10th of 11 higher than 2 of 11 other Polypharmacy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Polypharmacy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Improving Medication Management in World Trade Center Responders
RECRUITING · NA
-
The Geriatric Emergency Department Pharmacologic Harm Prevention Project
RECRUITING · NA
-
Effectiveness of PGx Testing
ACTIVE NOT RECRUITING · NA
-
Reducing High-Risk Geriatric Polypharmacy Via EHR Nudges R01 Trial
ACTIVE NOT RECRUITING · NA
-
Preemptive Pharmacogenomics Testing Among Geriatric Patients
ACTIVE NOT RECRUITING · NA
-
Pharmacist Intervention to Reduce Post-Hospitalization Utilization
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02861898 · 33 participants · Phase 1
Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma
- NCT04871607 · 33 participants · Phase 2
Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatment of Primary Refractory or Relapsed Hodgkin Lymphoma
- NCT05071937 · 33 participants · Phase 2
ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer
- NCT05168618 · 33 participants · Phase 2
Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer, The AtezoCab Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI